about
Epstein-Barr virus nuclear antigen 3C interacts with and enhances the stability of the c-Myc oncoproteinNm23-H1 modulates the activity of the guanine exchange factor Dbl-1Epstein-Barr virus latent antigen 3C can mediate the degradation of the retinoblastoma protein through an SCF cellular ubiquitin ligaseEpstein-Barr virus nuclear antigen 3C and prothymosin alpha interact with the p300 transcriptional coactivator at the CH1 and CH3/HAT domains and cooperate in regulation of transcription and histone acetylation.Epstein-Barr virus nuclear antigen 3C putative repression domain mediates coactivation of the LMP1 promoter with EBNA-2.Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen modulates K1 expression through its cis-acting elements within the terminal repeats.SCFSkp2 complex targeted by Epstein-Barr virus essential nuclear antigenLatency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus recruits uracil DNA glycosylase 2 at the terminal repeats and is important for latent persistence of the virusHuman Oncogenic Herpesvirus and Post-translational Modifications - Phosphorylation and SUMOylationThe Role of Gammaherpesviruses in Cancer PathogenesisEpigenetic Impact on EBV Associated B-Cell LymphomagenesisEpstein-Barr Virus: Diseases Linked to Infection and TransformationEarly events associated with infection of Epstein-Barr virus infection of primary B-cellsmiR-K12-7-5p encoded by Kaposi's sarcoma-associated herpesvirus stabilizes the latent state by targeting viral ORF50/RTAComprehensive analysis of LANA interacting proteins essential for viral genome tethering and persistenceA unique SUMO-2-interacting motif within LANA is essential for KSHV latencyMolecular biology of EBV in relationship to AIDS-associated oncogenesis.Kaposi's sarcoma-associated herpesvirus genome programming during the early stages of primary infection of peripheral blood mononuclear cells.Multiple oncogenic viruses identified in Ocular surface squamous neoplasia in HIV-1 patients.Kaposi's sarcoma-associated herpesvirus-encoded LANA can interact with the nuclear mitotic apparatus protein to regulate genome maintenance and segregation.Cellular corepressor TLE2 inhibits replication-and-transcription- activator-mediated transactivation and lytic reactivation of Kaposi's sarcoma-associated herpesvirus.EC5S ubiquitin complex is recruited by KSHV latent antigen LANA for degradation of the VHL and p53 tumor suppressors.Protein complexes associated with the Kaposi's sarcoma-associated herpesvirus-encoded LANA.Hypoxia inactivates the VHL tumor suppressor through PIASy-mediated SUMO modification.Epstein-Barr virus nuclear antigen 1 interacts with Nm23-H1 in lymphoblastoid cell lines and inhibits its ability to suppress cell migrationKaposi's sarcoma-associated herpesvirus reactivation is regulated by interaction of latency-associated nuclear antigen with recombination signal sequence-binding protein Jkappa, the major downstream effector of the Notch signaling pathwayInhibition of KAP1 enhances hypoxia-induced Kaposi's sarcoma-associated herpesvirus reactivation through RBP-Jκ.Microbial Signatures Associated with Oropharyngeal and Oral Squamous Cell Carcinomas.Epstein-Barr virus nuclear antigen 3C facilitates G1-S transition by stabilizing and enhancing the function of cyclin D1.Induction of Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen by the lytic transactivator RTA: a novel mechanism for establishment of latencyCollision of Three Pandemics: The Coexistence of Cervical Cancer, HIV Infection, and Prior Tuberculosis in the Sub-Saharan Country of BotswanaCoordination of KSHV latent and lytic gene control by CTCF-cohesin mediated chromosome conformation.Upregulation of cellular Bcl-2 by the KSHV encoded RTA promotes virion productionSingle molecule analysis of replicated DNA reveals the usage of multiple KSHV genome regions for latent replication.Epstein-Barr virus nuclear antigen 3C stabilizes Gemin3 to block p53-mediated apoptosis.Ubiquitin/SUMO modification regulates VHL protein stability and nucleocytoplasmic localization.Isolation and characterization of mouse and human esophageal epithelial cells in 3D organotypic culture.The RBP-Jκ binding sites within the RTA promoter regulate KSHV latent infection and cell proliferation.Oncogenic viruses associated with vulva cancer in HIV-1 patients in Botswana.Kaposi's sarcoma herpesvirus upregulates Aurora A expression to promote p53 phosphorylation and ubiquitylation
P50
Q24311421-F2CD3830-3328-4845-8AED-5BD060040E16Q24311795-8EC37129-7B9E-465F-BCFF-6FD7E444A291Q24535609-3FF6641E-A926-45A0-8794-ADC31075DF80Q24537547-CFD96BD0-DF13-4DC5-AE46-BD2BABA2E07BQ24540313-74463F02-C2EB-409D-A4DC-11160CFE16BFQ24543014-AC20D2E7-E25B-43BC-A279-9E889F0E669FQ24556627-A8D63AA0-A2AF-4D3F-AD33-EAD0895FDAFFQ24670086-66DD869A-3F12-4BB3-AE74-0082914916BEQ26744568-5A6F9312-1502-48E9-ABEF-93AE71555244Q26767186-E8E2B8AF-8472-4FA4-8D4A-2C4A81A4EA59Q28068361-176B2BDE-204E-4621-A910-F85741C27B37Q28074586-2D0C0430-3822-4B5D-877B-73702C0807B6Q28476230-D4D06F43-99C4-418F-9281-09EF2AEF2218Q28476790-CCFFCD0C-C419-4E8D-8ACA-18B8683504D0Q28533244-81C632E7-5202-4E55-BFF5-0A48D30ECAB8Q28535343-EFE03C26-61BA-46F8-A7F0-1F61E506FF9AQ30363183-3F4E2392-DB18-4A6E-8349-9E84C781C47BQ30369871-59F1880E-CC56-419D-ACEB-3915CBA98A34Q30387346-9EEA0ED1-791A-4D73-9744-BCEF9D52F632Q30482603-DCEE9EAF-F6E5-4F71-BAC2-614ACDDAD1B3Q30919397-8E31DC7D-15E0-4A60-A75A-9DA770537C31Q33261811-48FF0EB6-9E1D-4A9C-8FB0-C081E7304A2AQ33282107-47A2C718-F710-43BB-9500-AB9AF94F560EQ33543092-92E082F9-96C8-4D34-AA2E-C233712240ABQ33718191-5FE18B45-9246-48AB-BF79-11C5F7A82215Q33737793-BD00A811-97D2-406B-A1C2-B0A35C42A572Q33743831-236483BB-6507-41BC-BC4D-6D712F4D083CQ33826237-C9035342-4EBC-4DF0-A8A3-371DE7E3E11DQ33828576-D7C69D33-A2FC-4F9E-A6DE-9F564780F4EBQ33843211-17CCF4E0-D79D-48B9-9BC1-5257E6C9F23CQ33873223-A6B2954C-4DB4-4BFE-9851-1BA564D87F08Q34005284-5C71C972-3C99-4C9C-BB4F-7EB7234DDE07Q34013770-F00A1EDB-C434-406C-97B3-745B3D11EBCAQ34071388-C41AD32D-0363-4B27-BB2D-5B0040C0B577Q34102722-E58C41CE-3A34-467A-A9BB-689CC3B4B44FQ34115236-649094AC-B097-47AF-8EDA-BA1C78A1316BQ34125957-335C6DCA-FBDE-4BB9-902E-0E5C33AF5043Q34130213-5F013C05-499A-455E-B5CC-E8A4762ED122Q34182459-10DD3C0C-F419-4986-9354-2C97C42A9ED1Q34186981-5F8D8CF9-FA3B-4AA9-832C-C87A39732A6C
P50
description
researcher
@en
name
Erle S Robertson
@en
type
label
Erle S Robertson
@en
prefLabel
Erle S Robertson
@en
P31
P496
0000-0001-7296-8772